Micro-RNA Expression in Hypoplastic Left Heart Syndrome

Topkara, 2011, Role of microRNAs in cardiac remodeling and heart failure, Cardiovasc Drugs Ther, 25, 171, 10.1007/s10557-011-6289-5 Stauffer, 2013, miRNA expression in pediatric failing human heart, J Mol Cell Cardiol, 57, 43, 10.1016/j.yjmcc.2013.01.005 Miyamoto, 2014, Gene expression and beta-adrenergic signaling are altered in hypoplastic left heart syndrome, J Heart Lung Transpl, 33, 785, 10.1016/j.healun.2014.02.030 Sucharov, 2008, miRNA expression in the failing human heart: functional correlates, J Mol Cell Cardiol, 45, 185, 10.1016/j.yjmcc.2008.04.014 Bellsham-Revell, 2013, Serial magnetic resonance imaging in hypoplastic left heart syndrome gives valuable insight into ventricular and vascular adaptation, J Am Coll Cardiol, 61, 561, 10.1016/j.jacc.2012.11.016 Ohye, 2010, Comparison of shunt types in the Norwood procedure for single-ventricle lesions, N Engl J Med, 362, 1980, 10.1056/NEJMoa0912461 Callari, 2012, Comparison of microarray platforms for measuring differential microRNA expression in paired normal/cancer colon tissues, PLoS One, 7, e45105, 10.1371/journal.pone.0045105 Reddy, 2012, Dynamic microRNA expression during the transition from right ventricular hypertrophy to failure, Physiol Genomics, 44, 562, 10.1152/physiolgenomics.00163.2011 Miyamoto, 2014, Beta-adrenergic adaptation in paediatric idiopathic dilated cardiomyopathy, Eur Heart J, 35, 33, 10.1093/eurheartj/ehs229 Justice, 2010, The role of quaking in mammalian embryonic development, Adv Exp Med Biol, 693, 82, 10.1007/978-1-4419-7005-3_6 Zhao, 2003, Rho-associated kinases play an essential role in cardiac morphogenesis and cardiomyocyte proliferation, Dev Dyn, 226, 24, 10.1002/dvdy.10212 Sock, 2004, Gene targeting reveals a widespread role for the high-mobility-group transcription factor Sox11 in tissue remodeling, Mol Cell Biol, 24, 6635, 10.1128/MCB.24.15.6635-6644.2004 Jones, 2000, A novel family of bromodomain genes, Genomics, 63, 40, 10.1006/geno.1999.6071 Guo, 2011, RNA binding protein QKI inhibits the ischemia/reperfusion–induced apoptosis in neonatal cardiomyocytes, Cell Physiol Biochem, 28, 593, 10.1159/000335755 Hinrichsen, 2008, Phosphorylation of pRb by cyclin D kinase is necessary for development of cardiac hypertrophy, Cell Prolif, 41, 813, 10.1111/j.1365-2184.2008.00549.x Fossett, 2001, Conserved cardiogenic functions of the multitype zinc-finger proteins: U-shaped and FOG-2, Trends Cardiovasc Med, 11, 185, 10.1016/S1050-1738(01)00092-5 Rouf, 2008, Increased FOG-2 in failing myocardium disrupts thyroid hormone-dependent SERCA2 gene transcription, Circ Res, 103, 493, 10.1161/CIRCRESAHA.108.181487 Martin, 2010, Wnt/beta-catenin signalling regulates cardiomyogenesis via GATA transcription factors, J Anat, 216, 92, 10.1111/j.1469-7580.2009.01171.x van Berlo, 2010, The transcription factor GATA-6 regulates pathological cardiac hypertrophy, Circ Res, 107, 1032, 10.1161/CIRCRESAHA.110.220764 Li, 2013, miR-145 inhibits isoproterenol-induced cardiomyocyte hypertrophy by targeting the expression and localization of GATA6, FEBS Lett, 587, 1754, 10.1016/j.febslet.2013.04.018 Srivastava, 1997, Knowing in your heart what's right, Trends Cell Biol, 7, 447, 10.1016/S0962-8924(97)01150-1 Bar, 2003, Upregulation of embryonic transcription factors in right ventricular hypertrophy, Basic Res Cardiol, 98, 285, 10.1007/s00395-003-0410-2